Rx spending to grow 5.2% next year: CMS

Share this article:

The Affordable Care Act is expected to give drugmakers a big boost, a recent government forecast shows. The forecast, issued by the Centers for Medicare and Medicaid Services (CMS) and analyzed by Pharmalot, shows projected prescription drug spending is poised to grow 5.2% in 2014, vs. 0.6% growth in 2013 and vs. an 0.8% drop in spending in 2012.

Without the anticipated stimulus from Obamacare, prescription-drug spending would be 2.9% lower in 2014, the blog points out, suggesting "a clear benefit."

Of course, some drugmakers are likely to receive a bigger shot in the arm than others, but over time, CMS predicts the overall benefit will grow due to price hikes and wider utilization, translating into a 6.5% annual incrase in spending from from 2015 through 2022, due to a plateau in generic dispensing, a pick-up in income growth and earlier prescribing to an aged population.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.